Robotic Endoluminal Surgery Market Report 2026

Robotic Endoluminal Surgery Market Overview

• Robotic Endoluminal Surgery market size has reached to $1.45 billion in 2025 • Expected to grow to $3.33 billion in 2030 at a compound annual growth rate (CAGR) of 18.1% • Growth Driver: Increasing Adoption Of Minimally Invasive Surgeries Fueling The Growth Of The Market Due To Demand For Enhancing Surgical Precision, Reduced Trauma, And Faster Patient Recovery • Market Trend: AI?Enabled Navigation And Imaging Expansion In Robotic Endoluminal Platforms • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Robotic Endoluminal Surgery Market?

The robotic endoluminal surgery refers to the use of robot-assisted systems to perform minimally invasive procedures inside hollow organs and natural body lumens such as blood vessels, the gastrointestinal tract, and airways. These systems enable precise navigation, visualization, and manipulation of instruments within narrow and complex anatomical structures that are difficult to access through conventional surgery. By improving control, dexterity, and stability within internal passages, robotic endoluminal platforms enhance surgical accuracy, reduce tissue trauma, and support faster patient recovery. The main product types of robotic endoluminal surgery systems are surgical systems, accessories and instruments, and services. Surgical systems are robotic platforms designed to perform minimally invasive procedures within hollow organs through natural orifices or small incisions. These systems are used in applications including gastrointestinal surgery, urological surgery, pulmonary surgery, gynecological surgery, and others, among end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.

What Is The Robotic Endoluminal Surgery Market Growth Forecast?

The robotic endoluminal surgery market size is expected to see rapid growth in the next few years. It will grow to $3.33 billion in 2030 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to rising investment in surgical robotics research, growing integration of ai and machine learning in surgical platforms, increasing commercialization of flexible robotic systems, expanding clinical applications across gastrointestinal and vascular procedures, rising patient preference for faster recovery and reduced trauma. Major trends in the forecast period include technology advancements in flexible robotic endoscopes, innovations in capsule and micro-robotic devices, developments in ai-enabled navigation systems, research and developments in autonomous robotic surgery, advancements in real-time imaging and robotic visualization systems.

Global Robotic Endoluminal Surgery Market Segmentation

1) By Product Type: Surgical Systems, Accessories And Instruments, Services 2) By Application: Gastrointestinal Surgery, Urological Surgery, Pulmonary Surgery, Gynecological Surgery, Others 3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others Subsegments: 1) By Surgical Systems: Flexible Endoscopic Robots, Bronchoscopy Robots, Gastrointestinal Navigation Robots, Colorectal Endoluminal Robots, Esophageal Endoscopic Robots 2) By Accessories And Instruments: Robotic Endoscopic Tools, Robotic Catheters, Robotic Endoscopic Cameras, Robotic Biopsy Devices, Robotic Graspers And Scissors 3) By Services: Installation And Integration Services, Maintenance And Repair Services, Training And Education Services, Software Upgrade Services, Technical Support Services

What Is The Driver Of The Robotic Endoluminal Surgery Market?

The increasing adoption of minimally invasive surgeries is expected to propel the growth of the robotic endoluminal surgery market going forward. Minimally invasive surgeries refer to surgical procedures performed through small incisions or a single entry point, reducing patient trauma, recovery time, and risk of complications. Adoption of minimally invasive surgeries is rising as hospitals and patients increasingly prioritize shorter recovery times, reduced postoperative pain, lower complication risk, and minimal scarring compared with traditional open procedures. Robotic endoluminal surgery supports minimally invasive surgeries by enabling precise navigation and manipulation within internal lumens, such as the gastrointestinal or respiratory tracts. It improves patient outcomes by reducing tissue trauma, shortening recovery times, and enhancing procedural accuracy. For instance, in January 2025, according to Intuitive Surgical Inc., a US-based medical technology company, worldwide da Vinci procedures, a type of minimally invasive robotic-assisted surgery, grew approximately 18% in the fourth quarter of 2024 compared with the fourth quarter of 2023, full year 2024 procedures grew approximately 17% compared with 2023, and the company expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2025 as compared to 2024. Therefore, the increasing adoption of minimally invasive and single-port surgeries is driving the growth of the robotic endoluminal surgery industry.

Key Players In The Global Robotic Endoluminal Surgery Market

Major companies operating in the robotic endoluminal surgery market are Medtronic plc, Fujifilm Holdings Corporation, Intuitive Surgical Inc., Olympus Corporation, CMR Surgical Ltd., Noah Medical Inc., Distalmotion SA, Ronovo Surgical Inc., Stereotaxis Inc., Neocis Inc., MicroPort MedBot Co. Ltd., Virtual Incision Corporation, Asensus Surgical Inc., EndoQuest Robotics Inc., SS Innovations International Inc., Edge Medical Robotics, Moon Surgical, Robocath SAS, SurgEase Innovations, EndoTools Therapeutics SA, Microbot Medical Inc.

Global Robotic Endoluminal Surgery Market Trends and Insights

Major companies operating in the robotic endoluminal surgery market are focusing on developing advanced technologies, such as integrated artificial intelligence and real-time imaging systems, to boost procedural accuracy, enhance patient safety, and improve diagnostic efficiency. Integrated AI and advanced imaging systems refer to software enhancements that fuse machine learning with live procedure data to help physicians navigate complex anatomy and locate tissue targets with greater precision. For instance, in October 2025, Intuitive Surgical Inc., a US‑based medical technology company, received U.S. Food & Drug Administration (FDA) clearance for software advancements for the Ion endoluminal system. The cleared innovations include enhanced 3D visualization of the lung airway tree and the integration of AI-based imaging functionality, which aids in the identification of suspicious lung lesions during biopsy procedures. This integration is designed to provide more intuitive navigation and information, supporting physician decision-making for more precise tissue sampling. It aims to improve the system's utility in the early diagnosis of lung cancer, potentially leading to better patient outcomes.

What Are Latest Mergers And Acquisitions In The Robotic Endoluminal Surgery Market?

In July 2025, Olympus Corporation, a Japan‑based global medical technology company, partnered with Revival Healthcare Capital to jointly create Swan EndoSurgical, a new company dedicated to advancing robotic endoluminal surgery systems. Through this collaboration, Olympus Corporation and Revival Healthcare Capital aim to develop a novel robotic platform designed to transform gastrointestinal (GI) patient care by enabling enhanced precision, flexibility, and control for endoluminal procedures. Revival Healthcare Capital is a US-based healthcare private equity and investment firm.

Regional Insights

North America was the largest region in the robotic endoluminal surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Robotic Endoluminal Surgery Market?

The robotic endoluminal surgery market includes revenues earned by entities through robotic-assisted minimally invasive endoluminal procedures, real-time surgical navigation and guidance, procedure planning and simulation, clinician training and support, intraoperative monitoring, and technical maintenance and system integration. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Robotic Endoluminal Surgery Market Report 2026?

The robotic endoluminal surgery market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the robotic endoluminal surgery industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.